Nelson Advisors: Analysis of Lanas' Acquisition of indici and New Zealand Market Expansion
Transaction Architecture and Corporate Capital Allocation
Lanas has entered into a definitive agreement to acquire the primary care software platform indici, committing NZ$150 million over a two year deployment schedule to accelerate its digital health footprint across New Zealand. This capital injection forms part of a multi year expansion program that lifts the group's aggregate enterprise investment in the domestic market toward NZ$200 Million. Formed in late 2025 following the acquisition of Clanwilliam Group by founder and Chief Executive Officer Howard Beggs,
Dublin headquartered Lanas operates as an international healthcare software platform backed by private equity sponsor TA Associates, alongside syndicated institutional financing from Apollo managed funds, Hayfin Capital Management and Arcmont Asset Management. The organisation launched with more than $115 Million in dedicated acquisition facilities and an operational baseline generating in excess of $120 Million in annualised revenues.
Globally, Lanas maintains operations across 19 offices in more than 20 countries, employing approximately 900 people throughout the United Kingdom, Ireland, Australia, and New Zealand. Across its international software networks, the company processes more than one billion clinical documents and messages annually, supporting a clinical base that exceeds 40,000 general practitioners. In New Zealand, Lanas maintains active operational centres in Auckland and Christchurch with an existing staff base of over 160 personnel, which will expand as domestic engineering and implementation capacities scale.
Regional governance is supported by senior industry leadership, including Australian director Michael Boyce, alongside TA Associates directors Lovisa Lander and Morgan Seigler, who sit on the group's central board.
The capital deployment framework allocates financing across primary care software engineering, native artificial intelligence workflow automation, infrastructure modernization, and national interoperability protocols. Rather than functioning as a passive financial investor, Lanas operates a vertical software model designed to buy, integrate, and scale healthcare platforms, aiming to triple group scale through organic capability development and accretive regional mergers and acquisitions.
Metric / Parameter | Corporate Specification | Strategic Detail |
New Capital Commitment | NZ$150 million | Deployed across 24 months in New Zealand digital health assets. |
Cumulative NZ Exposure | Approaching NZ$200 million | Total domestic platform valuation post-indici completion. |
Sponsorship & Capital Partners | TA Associates, Apollo, Hayfin, Arcmont | Private equity ownership supported by committed institutional debt facilities. |
Enterprise Scale | >$120m Revenue; 900+ Global Staff | Global operating entity spanning 19 offices across three continents. |
Domestic Presence | 160+ Staff in NZ | Engineering, customer support, and administrative hubs in Auckland and Christchurch. |
Processing Capacity | >1 Billion Documents; >40,000 GPs | Cross-hemisphere clinical communications and electronic health records. |
Technological Architecture and Market Footprint of indici
Developed in New Zealand by Valentia Technologies and launched commercially in 2017 under the leadership of founder Dr. Ahmad Javad, indici was engineered as a cloud-native practice management system (PMS) and electronic health record (EHR) designed to supersede legacy client server models. Over nine years of commercial implementation, indici has expanded across more than 250 primary healthcare organisations and Primary Health Organisations (PHOs), notably serving the Pinnacle Midlands Health Network and undergoing extensive pilot implementations across the ProCare network—to capture and maintain more than 2 million active patient records.
The technical design of indici reflects modern software-as-a-service (SaaS) principles, relying on modular microservices, RESTful interfaces, and HL7 Fast Healthcare Interoperability Resources (FHIR) data schemas. This design allows general practices to bypass on-premise relational database maintenance, offering browser based access across disparate practice sites, remote consultation capabilities and automated synchronisation with central health registries. By consolidating administrative workflows, clinical consultations, e-prescribing, lab ordering, and billing into an integrated cloud interface, the platform addresses the operational friction common to older desktop software.
Under the structure of the Lanas acquisition, indici will preserve operational continuity as an autonomous business unit, maintaining its existing management team, support personnel, and client commitments. Dr. Ahmad Javad has been retained as a strategic product advisor to guide long-term engineering integration and clinical roadmaps. The partnership gives indici direct access to Lanas' shared infrastructure, international research capital, and balance sheet capacity, accelerating internal development in areas such as ambient AI scribing, automated clinical summaries, and population health stratification algorithms.
Operational Metric | indici Performance Indicator | Clinical and Market Significance |
Inception Date | 2017 | Modern cloud SaaS foundation without legacy codebase constraints. |
Customer Penetration | >250 Healthcare Organisations | Substantial presence across major primary networks like Pinnacle and ProCare. |
Patient Population | >2 Million Patient Records | Direct coverage of approximately 40% of the New Zealand population. |
Estimated Market Share | ~17.4% of Primary Care PMS | Primary cloud challenger to incumbent on-premise systems. |
Architectural Model | Cloud-native, HL7 FHIR APIs | Supports secure external API interoperability and web-based multi-site access. |
Executive Governance | Dr. Ahmad Javad (Product Advisor) | Strategic continuity for clinical workflows and public system integration. |
Macro Environment: Health New Zealand Reform and Public Investment
Lanas’ capital commitment coincides with structural reforms across New Zealand’s public health infrastructure overseen by Health New Zealand (Te Whatu Ora). The primary healthcare delivery system faces compound systemic strains: an aging population exhibiting multi chronic health profiles, significant clinician and nursing shortages, and escalating burnout driven by excessive administrative tasks. General practitioners spend a substantial proportion of daily consultation time navigating disconnected clinical portals, manually managing diagnostic results, and executing administrative compliance reporting.
To address these vulnerabilities, the government committed more than $450 Million in dedicated digital health funding in Budget 2026, which sits within an overall Vote Health operational expansion of more than $5.8 billion featuring a $1.37 Billion annual cost-pressure baseline uplift. Of this digital allocation, $300 Million over three years ($100 Million annually, reprioritised from capital to operating budgets) is directed to the Health Digital Investment Plan (HDIP) established by the Centre for Digital Modernisation of Health. The HDIP focuses on upgrading legacy infrastructure, modernising diagnostic radiology networks, and retiring end-of-life hardware across public facilities.
The remaining $153.6 million over four years ($34.2 Million in FY2026/27 and $39.8 million annually across the subsequent three years) is ring-fenced to harden healthcare cybersecurity frameworks. This defensive initiative was expedited following high-profile data security incidents involving primary care software suppliers MediMap and Manage My Health, which highlighted vulnerabilities in vendor data handling. The funding establishes continuous 24/7 security operations monitoring, deploys specialist external security teams, and introduces mandatory governance requirements across community-based clinical platforms.
At the operational layer, Health New Zealand is rolling out the Shared Digital Health Record (SDHR) data service to create a continuous longitudinal record across primary, community, and hospital environments.
Although core services such as the New Zealand ePrescription Service (NZePS) have successfully integrated into leading primary platforms and accommodated regulatory shifts extending maximum repeat prescription limits from 3 to 12 months, nationwide primary care rollout of the SDHR has encountered delays, moving target dates to mid-2027. These delays stem from public sector privacy impact reviews, enhanced technical verification procedures following recent cyber intrusions, and the complexities of federating data across divergent practice software. Lanas' capital deployment directly targets these technical milestones, ensuring indici and its partner applications meet stringent state-mandated security and data-sharing protocols.
National Initiative / Fund | Capital Allocation | Strategic Scope and Primary Care Interdependence |
Health Digital Investment Plan (HDIP) | $300.0 million (3 years) | Replaces aging clinical hardware and modernises central IT environments. |
Primary Cybersecurity Initiative | $153.6 million (4 years) | Establishes 24/7 threat monitoring and vulnerability management across clinics. |
Shared Digital Health Record (SDHR) | $4.0m baseline + HDIP envelope | Centralises nationwide clinical records; full GP onboarding targeted for mid-2027. |
NZ ePrescription Service (NZePS) | Digital Health Core Baseline | Powers paperless prescribing and manages 12-month repeat script reconciliations. |
Vote Health Operational Uplift | >$5.8 billion overall envelope | Delivers a $1.37 billion annual frontline uplift to manage operational overhead. |
Ecosystem Synergies and Primary Care Market Realignment
The integration of indici into Lanas creates an end-to-end primary care health-technology stack. Prior to this acquisition, Lanas held key assets across adjacent transactional and communication domains in New Zealand, consisting of HealthLink, Toniq, and KonnectNET. HealthLink serves as the foundational electronic data interchange (EDI) backbone for New Zealand healthcare, routing encrypted laboratory reports, radiology diagnostics, and specialist discharge summaries across general practices and district hospitals nationwide. Toniq provides practice management and dispensary systems for community pharmacies, processing dispensing workflows and synchronising with public drug subsidy registries. KonnectNET manages the secure exchange of medical questionnaires and underwriting verifications between primary care practices and life insurers.
Historically, these systems functioned as loosely coupled external nodes connecting to disparate primary care practice management systems. A clinician running a general practice encounter had to place lab orders or dispatch prescriptions through external protocols, relying on batch messaging and manual confirmation steps. By bringing indici into common ownership with HealthLink and Toniq, Lanas achieves end to end integration across the clinical pathway. A consultation captured in indici can transmit orders directly over HealthLink's network and integrate with Toniq's community dispensary endpoints via structured FHIR messages. This technical continuity eliminates data reentry, allows real-time notifications to general practitioners when patients collect critical medications, and reduces administrative burdens for clinical staff.
This consolidation also alters the competitive balance against dominant legacy supplier Medtech Global, which has long held a commanding share of New Zealand general practices via its Medtech 32 and Medtech Evolution products. Medtech's market position has historically been protected by substantial practice switching costs and proprietary database frameworks, which led to high-profile legal disputes with Valentia Technologies regarding data access routines used during indici conversions. The remaining independent competitor, MyPractice, serves a dedicated segment of the general practice market using traditional on-premise systems.
Concurrently, primary care clinic ownership is undergoing structural consolidation, highlighted by Tend Health’s $270 Million acquisition of Green Cross Health’s medical division, which incorporated The Doctors clinic network and encompasses approximately 90 primary sites and 550,000 registered patients. As clinics consolidate into larger corporate healthcare groups, operational priorities increasingly demand modern, browser-based cloud architectures capable of supporting flexible clinician rosters and centralized multi-site management. Backed by Lanas' capital resources, indici is positioned to contest large network tenders that were historically dominated by legacy desktop providers.
Platform / Corporate Entity | Core Specialisation | Technical Footprint | Competitive Strategy within New Zealand |
indici (Lanas) | Primary Care PMS / EHR | Cloud SaaS, Microservices, Open APIs | Expands via NZ$150m capital program and direct integration with Lanas group assets. |
Medtech Global | General Practice & Specialist PMS | On-premise (Medtech 32) & Cloud-hybrid (Evolution) | Leverages incumbent scale while migrating clinics toward API-enabled ecosystems. |
MyPractice | General Practice PMS | On-premise Client-Server Architecture | Defends traditional general practices with low-complexity infrastructure requirements. |
HealthLink (Lanas) | EDI Clinical Messaging Backbone | Proprietary National Secure Messaging Network | Operates as an open industry utility connecting clinics, labs, and tertiary facilities. |
Toniq (Lanas) | Community Pharmacy Management | Integrated Dispensary Software Systems | Deepens integration with primary e-prescribing and community health networks. |
Tend Health | Vertically Integrated Primary Provider | Proprietary App & Consolidated Clinic Fleet | Employs an operator-led model to digitise service delivery across 90 clinics. |
Regulatory Frameworks: Overseas Investment and Competition Review
The completion of the indici acquisition and the deployment of Lanas’ NZ$150 Million investment program depend on statutory clearances from domestic regulatory bodies. The scale of the transaction and the integration of essential medical data networks bring the transaction under the jurisdiction of the Overseas Investment Office (OIO) and the Commerce Commission.
The Overseas Investment Act 2005 requires foreign entities to secure consent prior to acquiring significant domestic business assets. Lanas meets the statutory definition of an "overseas person" due to its ultimate control by US-based private equity fund TA Associates and European investment partners. Because the transaction and related forward capital deployments exceed the NZ$100 Million statutory threshold for significant business assets, mandatory filing is required.
Because indici maintains health information for over two million individuals, the filing engages the OIO’s National Security and Public Order (NSPO) and National Interest assessment frameworks. Regulatory officials assess foreign ownership of sensitive digital infrastructure to ensure data security and preserve sovereign regulatory compliance. Given Lanas' commitments to retain all existing operational staff across its Auckland and Christchurch offices, and the retention of founder Dr. Ahmad Javad as a strategic advisor, the transaction aligns with statutory criteria regarding investor character, commercial capability, and domestic economic benefit.
Antitrust review is governed by Section 47 of the Commerce Act 1986, which empowers the Commerce Commission to evaluate whether an acquisition will substantially lessen competition in any relevant market. From a horizontal perspective, the transaction does not consolidate competing practice management platforms, as Lanas held no primary care PMS platform in New Zealand prior to acquiring indici. Direct horizontal competition between indici, Medtech and MyPractice will therefore persist.
Antitrust scrutiny will instead focus on vertical integration and foreclosure risks. Because HealthLink operates as an essential electronic messaging pathway used by almost all general practices, the Commission must assess whether Lanas could degrade HealthLink’s application performance for rival software vendors, raise messaging fees, or provide preferential integration terms to indici. A related question applies to Toniq's pharmacy terminals, examining whether indici could be configured to route prescriptions preferentially to Toniq dispensaries.
Because such practices would distort fair competition across general practice and community pharmacy markets, regulatory approval may require behavioural undertakings ensuring HealthLink and Toniq maintain open, non-discriminatory interoperability for competing systems under the national NZePS architecture. Lanas’ operating history in the UK and Ireland, where it has long maintained multi-vendor messaging standards, suggests the group can accept open-access conditions without compromising its operating model.
Long Term Industry Implications and Outlook
The strategic entry of Lanas into New Zealand's primary care sector reflects broader consolidation across the Australasian digital health market. As primary care transitions from localized, on-premise software toward interconnected cloud platforms, the capital requirements for continuous feature deployment, cyber defense, and national regulatory compliance increasingly exceed the capacity of small domestic vendors. By placing indici alongside HealthLink, Toniq, and KonnectNET, Lanas establishes a software portfolio capable of modernising routine healthcare workflows.
For general practices, this consolidation offers opportunities to relieve administrative workloads. Modern cloud architectures supported by corporate balance sheets can accelerate the deployment of native automation, remote consultation infrastructure, and collaborative clinical workflows, freeing up valuable clinician time for direct patient care. Furthermore, end to end integration across diagnostic messaging, primary records and community dispensing establishes the technical connectivity required to achieve Health New Zealand's Shared Digital Health Record goals.
This market evolution also creates structural dependencies for the health sector. Concentrating critical primary care software, diagnostic messaging pipelines, and pharmacy dispensing networks within a single private-equity-backed corporate entity heightens the need for ongoing regulatory oversight. Authorities will need to monitor software subscription pricing, protect open data portability, and enforce robust cybersecurity protocols. As Health New Zealand progresses toward its mid-2027 SDHR integration milestones, close coordination between public health administrators and integrated technology providers like Lanas will play an important role in delivering a secure, unified, and resilient digital health ecosystem across New Zealand.
Nelson Advisors > European Healthcare Technology Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV. www.nelsonadvisors.co.uk
Healthcare.Digital is the Google News approved HealthTech and MedTech Thought Leadership platform for Nelson Advisors, positioning them as a specialised authority on European Healthcare Technology M&A and strategic corporate development. https://www.healthcare.digital
Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb
Healthcare.Digital serves as a research platform for Nelson Advisors’ perspectives on deals, valuations and structural shifts reshaping Global Digital Health, MedTech, Healthcare AI and Health IT. https://www.healthcare.digital
Nelson Advisors is one of Europe's leading mergers and acquisitions advisory firms, exclusively dedicated to the dynamic and rapidly evolving healthcare technology sector. With a deep understanding of market dynamics and technological advancements, they empower innovative HealthTech companies and strategic investors to navigate complex transactions and achieve their growth ambitions. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech#MedTech#DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #FemTech#ConsumerHealth #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #Canada #Commonwealth #CorporateDivestitures #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #Genomics
Nelson Advisors
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ Events in 2026
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
HealthInvestor Healthcare Summit > September 2026, London, UK
World Health Summit 2026 > October 2026, Berlin, Germany
HLTH USA 2026 > October 2026, USA
Global Health Exhibition 2026 > October 2026, Riyadh, Saudi Arabia
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Leaders in Health Summit 2026 > November 2026, London, UK
Venture Capital World Summit > December 2026, Toronto, Canada
Meet Nelson Advisors @ Events in 2027
Digital Health Rewired > March 2027 > Birmingham, UK
Barclays Health Elevate > March 2027, London, UK
NHS ConfedExpo > June 2027 > Manchester, UK
HLTH Europe > June 2027, Amsterdam, Netherlands
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV. www.nelsonadvisors.co.uk
Comments